These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 1380149)

  • 1. Reversion of middle T antigen-transformed Rat-2 cells by Krev-1: implications for the role of p21c-ras in polyomavirus-mediated transformation.
    Jelinek MA; Hassell JA
    Oncogene; 1992 Sep; 7(9):1687-98. PubMed ID: 1380149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for the small GTPase Rac in polyomavirus middle-T antigen-mediated activation of the serum response element and in cell transformation.
    Urich M; Senften M; Shaw PE; Ballmer-Hofer K
    Oncogene; 1997 Mar; 14(10):1235-41. PubMed ID: 9121774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. smg/rap1/Krev-1 p21s inhibit the signal pathway to the c-fos promoter/enhancer from c-Ki-ras p21 but not from c-raf-1 kinase in NIH3T3 cells.
    Sakoda T; Kaibuchi K; Kishi K; Kishida S; Doi K; Hoshino M; Hattori S; Takai Y
    Oncogene; 1992 Sep; 7(9):1705-11. PubMed ID: 1323817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of AP-1 constitutive activity interferes with polyomavirus MT antigen transformation ability.
    Winnischofer SM; de Oliveira ML; Sogayar MC
    J Cell Biochem; 2003 Oct; 90(2):253-66. PubMed ID: 14505342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. trans-Dominant suppressor mutations of the H-ras oncogene.
    Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
    Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of pp60c-src kinase activity in FDC-P1 cells by polyoma middle-T antigen and hematopoietic growth factors.
    Muser J; Kaech S; Moroni C; Ballmer-Hofer K
    Oncogene; 1989 Dec; 4(12):1433-9. PubMed ID: 2480561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of pp60c-src protein kinase by herbimycin A in polyomavirus middle tumor antigen-transformed cells.
    Yang YW; Chang YH
    Anticancer Res; 1997; 17(5A):3273-9. PubMed ID: 9413159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras.
    MacKenzie KL; Franco S; Naiyer AJ; May C; Sadelain M; Rafii S; Moore MA
    Oncogene; 2002 Jun; 21(27):4200-11. PubMed ID: 12082607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation by polyoma virus middle T antigen.
    Courtneidge SA
    Cancer Surv; 1986; 5(2):173-82. PubMed ID: 2430702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of pp60c-src expression in rat and mouse fibroblasts by an inducible antisense gene: effects on serum regulation of growth and polyoma virus middle T function.
    Talmage DA; Riney C; Benjamin TL
    Cell Growth Differ; 1991 Jan; 2(1):51-8. PubMed ID: 1706618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM; Pegg AE
    Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor-I receptor.
    Surmacz E; Sell C; Swantek J; Kato H; Roberts CT; LeRoith D; Baserga R
    Exp Cell Res; 1995 May; 218(1):370-80. PubMed ID: 7737373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of doxorubicin on pp60c-src kinase activity in polyoma virus MT antigen transformed cells.
    Yang YW; Chang YH
    Anticancer Res; 1994; 14(6B):2529-35. PubMed ID: 7532928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acid receptor alpha suppresses polyomavirus transformation and c-fos expression in rat fibroblasts.
    Talmage DA; Lackey RS
    Oncogene; 1992 Sep; 7(9):1837-45. PubMed ID: 1380150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of pp60c-src tyrosine kinase specific activity in tumor-derived Syrian hamster embryo cells.
    Kanner SB; Parsons SJ; Parsons JT; Gilmer TM
    Oncogene; 1988 Apr; 2(4):327-35. PubMed ID: 2452399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T antigens' role in polyomavirus transformation: c-myc but not c-fos or c-jun expression is a target for middle T.
    Rameh LE; Armelin MC
    Oncogene; 1991 Jun; 6(6):1049-56. PubMed ID: 1648700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of azatyrosine-induced revertants from ras-transformed human mammary epithelial cells.
    Kyprianou N; Taylor-Papadimitriou J
    Oncogene; 1992 Jan; 7(1):57-63. PubMed ID: 1741165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of cytokeratin 14 gene expression by the polyoma virus middle T antigen is dependent on c-Src association but independent of full transformation in rat liver nonparenchymal epithelial cells.
    Royal I; Raptis L; Druker BJ; Marceau N
    Cell Growth Differ; 1996 Jun; 7(6):737-43. PubMed ID: 8780887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoplasmic interaction between pp60c-src and a truncated polyoma virus middle T antigen.
    Courtneidge SA; Read M; Wilson JB; Fried M
    Oncogene Res; 1989; 4(1):75-80. PubMed ID: 2497424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.